Actively Recruiting

Phase 4
Age: 21Years - 80Years
All Genders
NCT06793982

Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain

Led by LifeBridge Health · Updated on 2025-03-14

54

Participants Needed

1

Research Sites

92 weeks

Total Duration

On this page

Sponsors

L

LifeBridge Health

Lead Sponsor

H

Hip Society

Collaborating Sponsor

AI-Summary

What this Trial Is About

Prospective, single-center that may go on to being multicenter, randomized trial comparing platelet rich plasma (PRP) versus corticosteroid injection for the treatment of symptoms of Hip osteoarthritis. The purpose of the study is to determine which therapy provides a greater reduction in patient reported outcome measures of pain and function.

CONDITIONS

Official Title

Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain

Who Can Participate

Age: 21Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed and dated informed consent form provided
  • Willingness to comply with all study procedures and available for the study duration
  • Male or female aged 21 to 80 years
  • Radiographic diagnosis of Kellgren-Lawrence grade II or III hip osteoarthritis
  • Indicated for a hip injection to treat hip osteoarthritis symptoms
Not Eligible

You will not qualify if you...

  • Any injection into the target hip within the past three months
  • Current skin infection over the injection area
  • Current or previous diagnosis of chronic pain
  • Opioid tolerance at screening (daily usage for a week or longer of specified opioid doses)
  • Allergy to any ingredients or medications used in the study
  • Treatment with another investigational drug or intervention for pain
  • Diagnosis of diabetes mellitus
  • Female participants who are pregnant or planning pregnancy within three months or study duration
  • Any physical or psychological condition that would prevent participation according to the investigator's opinion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Sinai Hospital of Baltimore

Baltimore, Maryland, United States, 21215

Actively Recruiting

Loading map...

Research Team

M

Martin Gesheff, DHSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here